View Item 

Show simple item record

Phase II Trial of Vorinostat plus Tacrolimus and Mycophenolate to Prevent Graft versus Host Disease Following Reduced Intensity Conditioning Related Donor Allogeneic Transplant

dc.contributor.authorChoi, Sung Won
dc.contributor.authorReddy, Pavan
dc.date.accessioned2013-10-21T23:21:19Z
dc.date.available2013-10-21T23:21:19Z
dc.date.issued2013-10-21
dc.identifier.urihttps://hdl.handle.net/2027.42/100248
dc.descriptionUMCC 2008.095 Protocolen_US
dc.description.sponsorshipFUNDING Merck and Co., Inc., Leukemia and Lymphoma Society, National Institutes of Health (R01CA143379, 1K23AI091623, P01CA039542, P30CA047904, R01AI15614), St. Baldrick’s Foundation, and Michigan Institute for Clinical and Health Research UL1TR00043.en_US
dc.language.isoen_USen_US
dc.subjectGVHD Vorinostat HDAC Inhibition Allogeneic HSCT Reduced Intensity Conditioningen_US
dc.titlePhase II Trial of Vorinostat plus Tacrolimus and Mycophenolate to Prevent Graft versus Host Disease Following Reduced Intensity Conditioning Related Donor Allogeneic Transplanten_US
dc.typeOtheren_US
dc.subject.hlbsecondlevelPediatrics
dc.subject.hlbtoplevelHealth Sciences
dc.contributor.affiliationumPediatrics and Communicable Diseasesen_US
dc.contributor.affiliationumInternal Medicineen_US
dc.contributor.affiliationumcampusAnn Arboren_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/100248/1/umcc_2008 095_protocol.pdf
dc.owningcollnamePediatrics and Communicable Diseases, Department of


Files in this item

Name:
umcc_2008 095_protocol.pdf
Size:
807.9KB
Format:
PDF
Description:
Phase 1/2 Trial of Vorinostat ...
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.